ESSA Pharma Inc (EPIX)
6.97
+0.02
(+0.29%)
USD |
NASDAQ |
May 03, 16:00
6.97
0.00 (0.00%)
After-Hours: 19:07
ESSA Pharma Shareholders Equity (Quarterly): 140.68M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 140.68M |
| September 30, 2023 | 145.63M |
| June 30, 2023 | 150.24M |
| March 31, 2023 | 156.34M |
| December 31, 2022 | 162.02M |
| September 30, 2022 | 167.12M |
| June 30, 2022 | 171.52M |
| March 31, 2022 | 178.71M |
| December 31, 2021 | 187.54M |
| September 30, 2021 | 194.01M |
| June 30, 2021 | 199.70M |
| March 31, 2021 | 205.41M |
| December 31, 2020 | 74.10M |
| September 30, 2020 | 79.24M |
| June 30, 2020 | 36.94M |
| March 31, 2020 | 40.28M |
| December 31, 2019 | 46.03M |
| September 30, 2019 | 48.98M |
| June 30, 2019 | 0.6188M |
| Date | Value |
|---|---|
| March 31, 2019 | 3.664M |
| December 31, 2018 | 6.778M |
| September 30, 2018 | 9.152M |
| June 30, 2018 | 10.94M |
| March 31, 2018 | 13.37M |
| December 31, 2017 | -6.317M |
| September 30, 2017 | -4.274M |
| June 30, 2017 | -2.178M |
| March 31, 2017 | -5.899M |
| December 31, 2016 | 1.470M |
| September 30, 2016 | -0.5369M |
| June 30, 2016 | 3.264M |
| March 31, 2016 | 6.884M |
| December 31, 2015 | 0.6685M |
| September 30, 2015 | 4.456M |
| June 30, 2015 | 4.386M |
| March 31, 2015 | 8.917M |
| December 31, 2014 | 3.009M |
| September 30, 2014 | 1.974M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.6188M
Minimum
Jun 2019
205.41M
Maximum
Mar 2021
125.53M
Average
150.24M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
| Xenon Pharmaceuticals Inc | 927.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 144.49M |
| Total Liabilities (Quarterly) | 3.806M |